What is the main business of IBG Intl?

The main business activity of IBG Intl focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 27, 2015.

Where is the headquarters located?

The headquarters is located at: ul. Skalista 54C, 25-435 Kielce.

What is the legal form?

The legal form of this entity is a limited partnership (sp.k.).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

In 2024, the company generated total revenue of $502,137, representing a decrease of 2.8% compared to 2023.

Yes, the company recorded a net profit of $266,748 in 2024, meaning the company decreased its profit by 40.5%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $12,168 in 2024, representing 100% of all operating expenses.

IBG Intlsp. z o.o. + limited partnership

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2015-02-27

Registered address

ul. Skalista 54C, 25-435 Kielce, Poland

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 44 days early.

202525/06/2026
202401/07/2025
202315/07/2024
202219/05/2023
202120/05/2022
201919/06/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 95.55kMedianUSD 55.24kAverageUSD 2.70m

Net profit

This companyUSD 45.04kMedianUSD -1.27kAverageUSD -92.18k

Operating costs

This companyUSD 12.20kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 4.15mMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Aleksander Chmielewski – Attorney-in-fact (sole)

Koenraad Cruycke – Attorney-in-fact (sole)

Krzysztof Sebastian Panek – Attorney-in-fact (sole)

Manner of representation

The general partners represent the company independently.

Partners

Partners
Aleksander Chmielewskiage 56
Koenraad Cruyckeage 61
INTL sp. z o.o.
Krzysztof Sebastian Panekage 56

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2010-02-15.

BNP Paribas Bank Polska
35 1600 1273 1847 8321 5000 0001
BNP Paribas Bank Polska
78 1600 1273 1847 8321 5000 0003

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 26, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Kielce

Competitors

Name	Revenue	Website
Relvosp. z o.o.	$120,693.26	relvo.pl
Microblicsp. z o.o.	$122,383.50	microblic.pl
Biodecsp. z o.o.	$115,508.63	biodec.pl
IntelliseqS.A.	$111,419.60	intelliseq.pl
ModicaP.S.A.	$103,400.72	modica.bio
Microbe Plussp. z o.o.	$104,197.26	microbe-plus.com
WPD Pharmaceuticalssp. z o.o.	$90,822.78	wpdpharmaceuticals.com
WPD PharmaceuticalsS.A.	$87,561.70	wpdpharmaceuticals.pl
Xenstatssp. z o.o.	$66,774.27	xenstats.com
Pominnosp. z o.o.	$65,991.17	pominno.pl